Nicholas Grund

Nicholas Grund is an experienced executive in the biotechnology and pharmaceutical industries, currently serving as the Chief Commercial Officer at Akebia Therapeutics since January 2024. Previously, Grund held various leadership roles, including President at Eurofins Transplant Genomics and Chief Commercial Officer at AMAG Pharmaceuticals, where oversight of multiple business units and a focus on efficiency were key responsibilities. Grund also founded NG Strategy Consulting, providing expertise to biotech firms in the rare disease sector. With a robust background at Sanofi and Bayer, encompassing roles such as Senior Vice President and Manager of Financial Planning and Analysis, Grund has consistently driven strategic organizational changes and market leadership initiatives. Nicholas Grund holds a Master of Business Administration from the D'Amore-McKim School of Business at Northeastern University.